Latest papers

Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1.

CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophagy in HepG2 E47 cells.

Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.

Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.

Role of hepatic desaturases in obesity-related metabolic disorders.

The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease.

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice.

The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.

Novel insights into the pathophysiology of nonalcoholic fatty liver disease.

Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.

Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice.

Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis.

Increased susceptibility to experimental steatohepatitis induced by methionine-choline deficiency in HBs-Tg mice.

The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat.

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice.

[Complications of obesity--pathogenesis].

[Chronic liver disease related to impaired glucose tolerance].

Antioxidant and hepatoprotective effects of extract of ginkgo biloba in rats of non-alcoholic steatohepatitis.